About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Thermo Fisher Scientific Showcases Clinical Research Innovation at DIA Annual Meeting

PPD clinical research business leads real-world data and technology panel, receives CRO Leadership Award

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, is embracing the theme of the 60th annual Drug Information Association (DIA) annual meeting today in San Diego – “Charting New Horizons.” The same day the business earns a CRO Leadership Award for the 13th consecutive year, it’s also hosting a DIA innovation panel for customers on accelerating drug development with real-world data and technology.

“Innovation is the lifeblood of clinical research, and in today’s complex drug-development environment, pharmaceutical and biotech leaders not only seek data-driven and technology-forward solutions, but trusted partnership and exceptional service delivery,” said Sebastian Pacios, M.D., senior vice president and president, clinical research, Thermo Fisher Scientific. “We’re honored to receive a CRO Leadership Award recognizing our performance for our customers. We’re proud to offer comprehensive drug development products and services including integrated CRO and CDMO solutions, which provide customers a wide range of innovative capabilities to streamline the drug development journey from molecule to medicine to market.”

The DIA innovation panel, “Accelerating Drug Development through the Convergence of RWD and Technology,” led by experts from Thermo Fisher’s PPD clinical research business, will focus on how the proliferation of real-world data (RWD) sources and advancements in technology, including artificial intelligence and wearables, have fueled the use of real-world evidence (RWE) in drug development. This intersection provides invaluable insights to help researchers make smarter, faster decisions to advance and optimize product development. The panel features clinical research leaders Gino Pirri, vice president, product and technology; Ariel Berger, MPH, executive director, integrated solutions, Evidera; John Van Hoy, MBA, executive director, data science and advanced analytics; and moderator Peter Wahl, MLA, MS, ScD, vice president and global head of scientific affairs, CorEvitas. DIA attendees are invited to join the panel discussion today at 12:55 p.m. PDT in Innovation Theater #2 in the exhibit hall at the San Diego Convention Center and meet with the PPD clinical research team in booth #1327 in the exhibit hall.

Today also marks the 13th consecutive year the PPD clinical research business has been honored in the CRO Leadership Awards, a partnership between two Life Science Connect publications, Clinical Leader and Life Science Leader, and Industry Standard Research (ISR), the organization’s research affiliate. Based on research from ISR’s annual quality benchmarking surveys, CRO services are evaluated on more than 20 performance metrics. Research participants are recruited from a wide range of pharmaceutical, biotech and medical device companies and are screened for decision-making influence and authority with clinical research suppliers. The awards are presented in five categories: capabilities, compatibility, expertise, quality and reliability. The PPD clinical research business was recognized in all five categories.

Thermo Fisher’s connected capabilities across drug development include a streamlined clinical research, development and manufacturing organization (CRDMO) solution, combining the expertise and technology of a contract research organization (CRO) and a contract development and manufacturing organization (CDMO) – delivering speed, simplicity and scalability to clinical trials, drug development and manufacturing. Coordinating activities across all stages of drug development with integrated CRO and CDMO solutions ensures simplified and scalable pathways, from concept to market. One innovative Thermo Fisher solution is integrating investigational product manufacturing, clinical trial delivery and clinical supplies logistics into a unified process, simplifying and accelerating drug development and enhancing the trial participation experience for patients and research sites.

Also at DIA, the company unveiled a new brand look for PPD clinical research services to align with the Thermo Fisher brand. The brand evolution modernizes the appearance and visually represents Thermo Fisher’s connected capabilities.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  216.48
+3.44 (1.61%)
AAPL  262.24
+9.95 (3.94%)
AMD  240.56
+7.48 (3.21%)
BAC  52.04
+0.76 (1.48%)
GOOG  257.02
+3.23 (1.27%)
META  732.17
+15.26 (2.13%)
MSFT  516.79
+3.21 (0.63%)
NVDA  182.64
-0.58 (-0.32%)
ORCL  277.18
-14.13 (-4.85%)
TSLA  447.43
+8.12 (1.85%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.